603858 步長製藥
按盤價 
17.910 +1.030 (+6.102%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.021 | 2.660 | -11.476 | 8.297 | 13.610 |
| 總資產報酬率 ROA (%) | 1.112 | 1.489 | -6.679 | 4.972 | 8.445 |
| 投入資產回報率 ROIC (%) | 1.491 | 2.021 | -8.879 | 6.483 | 10.386 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.007 | 68.152 | 71.691 | 73.781 | 76.628 |
| 營業利潤率 (%) | 7.541 | 3.292 | -8.357 | 10.281 | 14.777 |
| 息稅前利潤/營業總收入 (%) | 8.531 | 3.671 | -7.664 | 10.958 | 15.486 |
| 淨利潤/營業總收入 (%) | 3.335 | 1.147 | -10.641 | 7.031 | 11.515 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.836 | 258.509 | -135.174 | 101.889 | 91.822 |
| 價值變動淨收益/利潤總額(%) | 0.067 | 4.799 | -0.217 | -2.672 | 0.662 |
| 營業外收支淨額/利潤總額(%) | -1.388 | -10.509 | 0.788 | -2.143 | -0.198 | 償債能力分析 |
| 流動比率 (X) | 1.281 | 1.208 | 1.292 | 1.166 | 1.022 |
| 速動比率 (X) | 0.524 | 0.489 | 0.747 | 0.631 | 0.668 |
| 資產負債率 (%) | 46.921 | 45.549 | 44.082 | 39.967 | 39.654 |
| 帶息債務/全部投入資本 (%) | 24.717 | 20.705 | 20.117 | 19.062 | -- |
| 股東權益/帶息債務 (%) | 291.316 | 365.294 | 379.042 | 411.068 | 397.511 |
| 股東權益/負債合計 (%) | 116.047 | 122.075 | 127.755 | 149.940 | 151.118 |
| 利息保障倍數 (X) | 7.803 | 5.304 | -10.093 | 12.278 | 20.982 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 42.898 | 42.500 | 37.214 | 32.139 | 0.000 |
| 存貨周轉天數 (天) | 375.006 | 372.069 | 324.192 | 287.493 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
